1. Home
  2. HRMY vs EXK Comparison

HRMY vs EXK Comparison

Compare HRMY & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$38.12

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Endeavour Silver Corporation (Canada)

EXK

Endeavour Silver Corporation (Canada)

HOLD

Current Price

$10.66

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
EXK
Founded
2017
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.2B
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
HRMY
EXK
Price
$38.12
$10.66
Analyst Decision
Buy
Strong Buy
Analyst Count
9
4
Target Price
$44.11
$13.94
AVG Volume (30 Days)
881.8K
7.3M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
7.97
N/A
EPS
1.84
N/A
Revenue
$868,453,000.00
N/A
Revenue This Year
$19.75
$69.59
Revenue Next Year
$12.88
$17.61
P/E Ratio
$20.92
N/A
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$5.29
52 Week High
$40.87
$15.15

Technical Indicators

Market Signals
Indicator
HRMY
EXK
Relative Strength Index (RSI) 56.72 70.45
Support Level $34.87 $10.50
Resistance Level $39.24 $11.60
Average True Range (ATR) 1.33 0.45
MACD 0.14 0.30
Stochastic Oscillator 66.49 89.99

Price Performance

Historical Comparison
HRMY
EXK

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About EXK Endeavour Silver Corporation (Canada)

Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.

Share on Social Networks: